Login/Sign Up
₹15498*
MRP ₹18900
18% off
₹16065*
MRP ₹18900
15% CB
₹2835 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Provide Delivery Location
Online payment accepted
Whats That
About Darzalex Injection
Darzalex Injection belongs to the group of monoclonal antibodies (anti-cancer medicines) used to treat a type of blood cancer called multiple myeloma in adults 18 years or older. Multiple myeloma, also known as myeloma, is a type of bone marrow cancer that affects several areas of the body, such as the spine, skull, pelvis, and ribs.
Daratumumab, a monoclonal antibody, is present in Darzalex Injection. Daratumumab is meant to bind to certain cancer cells in your body, either directly killing multiple myeloma cells and/or allowing your immune system to identify and destroy them.
Darzalex Injection should be administered to patients only in a hospital setting under the supervision of a physician qualified by training and experience to administer cancer chemotherapeutic agents. Sometimes, you may experience common side effects, such as Chills, sore throat, cough, feeling sick (nausea), vomiting, itchy, runny or blocked nose, feeling short of breath or other breathing problems, chest discomfort, dizziness or light-headedness (hypotension), itching and wheezing. Most of these side effects do not require medical attention and will resolve gradually over time. However, you are advised to talk to your doctor if any of these side effects persist or worsen.
Before taking the Darzalex Injection, inform your doctor about all your allergic or hypersensitivity reactions to medicines or food. Darzalex Injection can cause fetal harm when administered to a pregnant woman. It is critical not to become pregnant or get pregnant while undergoing therapy and for several months afterwards. Before beginning treatment, discuss effective contraception with your healthcare professional. Inform them immediately if you or your partner becomes pregnant while undergoing therapy. Breastfeeding is usually not advised during this treatment since it is unknown whether this medication passes into breast milk. Alcohol should be avoided during treatment with this medicine. Drive only if alert, as the Darzalex Injection may cause drowsiness or dizziness.
Uses of Darzalex Injection
Directions for Use
Medicinal Benefits
Daratumumab, a monoclonal antibody, is present in Darzalex Injection. Monoclonal antibodies are proteins that recognize and bind to specific targets within the body. Daratumumab is a targeted monoclonal antibody meant to bind to certain cancer cells in your body that helps slow or stop the progression of multiple myeloma; it directly kills multiple myeloma cells and/or allows your immune system to identify and destroy them.
Storage
Drug Warnings
Before taking Darzalex Injection, inform your doctor about your medical history and other medications you are currently taking to rule out any potential negative effects. Avoid taking Darzalex Injection if you are pregnant or breastfeeding or allergic to any component present in Darzalex Injection. Both women and men using this Darzalex Injection should use birth control to avoid pregnancy. Inform your doctor if you have a history of low blood pressure; your doctor will closely monitor and manage it. If you are taking medication to help lower your blood pressure, you may need to reduce or discontinue it while taking Daratumumab.
Diet & Lifestyle Advise
Habit Forming
Therapeutic Class
Product Substitutes
We provide you with authentic, trustworthy and relevant information
Daratumumab, a monoclonal antibody, is present in Darzalex Injection. Monoclonal antibodies are proteins that recognize and bind to specific targets within the body. Daratumumab directly kills multiple myeloma cells and/or allows your immune system to identify and destroy them.
No, it is unsafe to father a child while taking Darzalex Injection. It is recommended for sexually active men to use condoms while on treatment and for at least six months after their last dose of Darzalex Injection.
Darzalex Injection can affect the results of this blood test. Tell the person doing the test that you are using Darzalex Injection.
Based on the medical condition, Darzalex Injection may be given alone or together with other medicines used to treat multiple myeloma.
Tell your healthcare professional immediately if you get any signs of an infusion-related reaction during or three days after the infusion. Your doctor may give other medicines, or the infusion may need to be slowed down or stopped.
Darzalex Injection can cause a significant decrease in the number of blood cells and platelets. Your doctor may suggest laboratory tests before and during the treatment. Tell your healthcare provider if you develop a fever or have signs of bruising or bleeding.
Drug-Drug Interactions Checker List
Special Advise
Disease/Condition Glossary
Myeloma, also called multiple myeloma, is a cancer of the plasma cells. Plasma cells are white blood cells that make antibodies that protect us from infection. In myeloma, the cells grow too much, crowding out normal cells in the bone marrow that make red blood cells, platelets, and other white blood cells. Multiple myeloma, the most common type of plasma cell tumour, develops in the bone marrow and can spread throughout the body.
Have a query?